-
Tamoxifen citrate, a selective non-steroidal estrogen receptor antagonist, was approved by FDA as a drug that is utilized in the treatment of estrogen receptor–positive breast cancer. Tamoxifen Citrate是一种雌激素受体拮抗剂，与雌激素竞争性结合。
More
-
Lapatinib Ditosylate is the xylenesulfonic acid salt form of lapatinib (GW-572016), a small-molecule dual inhibitor of EGFR and ErbB2 receptor kinase activities. Lapatinib ditosylate (甲苯磺酸拉帕替尼; GW-572016 ditosylate) 是EGFR和ErbB2抑制剂，IC50分别为10.8和9.2 nM。
More
-
ZLN005, also known as 2-(4-tert-Butylphenyl) benzimidazole, is a PGC-1α transcriptional regulator shows antidiabetic efficacy in a mouse model. ZLN005是新型过氧化物增殖激活受体协同激活子（PGC-1α）转录调节剂。
More
-
(+)-JQ1, an active enantiomer of JQ1, is a potent, highly specific and Kac-competitive inhibitor of bromodomain and extraterminal domain (BET) proteins, blocks BRD4 resulting in inhibition of c-Myc expression and tumor growth. (+)-JQ1是一种BET bromodomain抑制剂，作用于BRD4(2)，IC50为33 nM，结合到BET家族的所有Bromodomain结构域，而不结合到BET家族以外的Bromodomain结构域。
More
-
Ricolinostat (ACY-1215) is an oral, first-in-class, selective inhibitor of HDAC6, and inhibits tubulin deacetylase. Rocilinostat (ACY-1215)是高效HDAC6抑制剂，IC50为5 nM，比对HDAC1/2/3的抑制性高10倍以上，对HDAC8有微弱活性，对HDAC4/5/7/9/11，Sirtuin1和Sirtuin2活性最低。
More
